Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10004450HBVENSG00000144285.24protein_codingSCN1ANoNo6323P35498
TVIS10014518HBVENSG00000144285.24protein_codingSCN1ANoNo6323P35498
TVIS10028748HBVENSG00000144285.24protein_codingSCN1ANoNo6323P35498
TVIS10044726HBVENSG00000144285.24protein_codingSCN1ANoNo6323P35498
TVIS10050751HBVENSG00000144285.24protein_codingSCN1ANoNo6323P35498
TVIS20037117HPVENSG00000144285.24protein_codingSCN1ANoNo6323P35498
TVIS20037956HPVENSG00000144285.24protein_codingSCN1ANoNo6323P35498
TVIS20031703HPVENSG00000144285.24protein_codingSCN1ANoNo6323P35498
TVIS20065419HPVENSG00000144285.24protein_codingSCN1ANoNo6323P35498
TVIS20055383HPVENSG00000144285.24protein_codingSCN1ANoNo6323P35498
TCGA Plot Options
Drug Information
GeneSCN1A
DrugBank IDDB00243
Drug NameRanolazine
Target IDBE0004901
UniProt IDQ8IWT1
Regulation Typeinhibitor
PubMed IDs26979079; 26459200; 16640453
CitationsRayner-Hartley E, Sedlak T: Ranolazine: A Contemporary Review. J Am Heart Assoc. 2016 Mar 15;5(3):e003196. doi: 10.1161/JAHA.116.003196.@@Saad M, Mahmoud A, Elgendy IY, Richard Conti C: Ranolazine in Cardiac Arrhythmia. Clin Cardiol. 2016 Mar;39(3):170-8. doi: 10.1002/clc.22476. Epub 2015 Oct 13.@@Jerling M: Clinical pharmacokinetics of ranolazine. Clin Pharmacokinet. 2006;45(5):469-91. doi: 10.2165/00003088-200645050-00003.
GroupsApproved; Investigational
Direct ClassificationAnisoles
SMILESCOC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2=C(C)C=CC=C2C)CC1
Pathways
PharmGKBPA164746007
ChEMBLCHEMBL1404